News

  • ARLG Leaders Recognized as Experts in Staphylococcus aureus and Bacteremia by Expertscape

    Congratulations to the ARLG’s co-principal investigators, Vance Fowler, MD, MHS, Duke University, and Henry “Chip” Chambers, MD, UCSF, as well as a number of other ARLG investigators who have been recognized as world experts in Staphylococcus aureus by Expertcape. In addition, Dr. Fowler  was recognized as the number one world expert in bacteremia by Expertscape. Other ARLG ... Read more
  • Robert Bonomo, Antibiotic Resistance Expert, Awarded Distinguished University Professorship

    Congratulations to Robert Bonomo, MD, ARLG Laboratory Center Co-Director, who was named a Distinguished University Professor at Case Western Reserve University (CWRU) during its fall convocation on August 28, 2019. CWRU awards the title of “Distinguished University Professor”— a permanent, honorific title, to acknowledge contributions of full-time, tenured faculty with exceptional records of research, scholarship, teaching, ... Read more
  • ARLG Study Employs Innovative Model to Test Diagnostics for Extragenital Gonorrhea

    Molecular diagnostic assays have transformed the field of infectious diseases, allowing for swift and sensitive detection of organisms previously challenging to diagnose, but it can be difficult to study how these new tests perform. Members of the Antibacterial Resistance Leadership Group (ARLG), which is facilitated by the Duke Clinical Research Institute, recently conducted a study ... Read more
  • ARLG Joins Forces with COMBACTE on a Number of Initiatives Designed to Fight Drug-resistant Infections

    The U.S.-based Antibacterial Resistance Leadership Group (ARLG), part of the Duke Clinical Research Institute (DCRI) and the University Medical Center (UMC) Utrecht, the managing entity of the COMBACTE (Combatting Bacterial Resistance in Europe) consortium, will work together to solidify a comprehensive global community to combat the threat of antibiotic resistance around the world. “We at the ARLG have long admired the work being done by COMBACTE to increase the efficacy of antimicrobial drug development,” said Vance Fowler, MD, an investigator at the DCRI and co-principal investigator of the ARLG. “Combining our efforts will allow us to maximize the work we both do to stop the advancement of antibacterial resistance.” Read more

Antibiotic Resistance in the News:

Diagnostic developers target antibiotic resistance : Nature News & Comment

Diagnostic developers target antibiotic resistance, Nature.com, October 9, 2015

NIH Funds Nine Antimicrobial Resistance Diagnostics Projects, NIAID, April 9, 2015

Obama battles 'superbugs' with national plan, CNN.com, March 27, 2015

Combating Antibiotic Resistance, FDA, October 14, 2014

National Strategy to Combat Antibiotic-Resistant Bacteria, CDC, September 22, 2014

New Executive Actions to Combat Antibiotic Resistance and Protect Public Health, Whitehouse.gov, September 18, 2014

Executive Order -- Combating Antibiotic-Resistant Bacteria, whitehouse.gov, September 18, 2014

PCAST Releases New Report on Combating Antibiotic Resistance, whitehouse.gov, September 18, 2014

Antimicrobial resistance, WHO, April 2014